Skip to main content

ORIGINAL RESEARCH article

Front. Immunol.
Sec. Alloimmunity and Transplantation
Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1545185
This article is part of the Research Topic Finding New Hope in Old Treatments: Repurposing Immunotherapy in Transplantation View all 5 articles

Comprehensive analysis of immunogenic cell death-related genes in liver ischemic reperfusion injury

Provisionally accepted
Kai Lu Kai Lu 1Hanqi Li Hanqi Li 1*Liankang Sun Liankang Sun 1*Xuyuan Dong Xuyuan Dong 2*Yangwei Fan Yangwei Fan 2*Danfeng Dong Danfeng Dong 2*Yinying Wu Yinying Wu 2*Yu Shi Yu Shi 2*
  • 1 Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shanxi, China
  • 2 Department of Oncology, First Affiliated Hospital of Xi'an Jiaotong University, Xi’an, Shaanxi, China

The final, formatted version of the article will be published soon.

    Background: Liver ischemic-reperfusion injury (LIRI) is a critical condition after liver transplantation. Understanding the role of immunogenic cell death (ICD) may provide insights into its diagnosis and potential therapeutic targets. Methods: Differentially expressed genes (DEGs) between LIRI and normal samples were identified, and pathway enrichment analyses were performed, followed by immune infiltration assessment through the CIBERSORT method. The consensus clustering analysis was conducted to separate LIRI clusters and single-sample Gene Set Enrichment Analysis (ssGSEA) was used to analyze the distinct immune states between clusters.Weighted Gene Co-Expression Network Analysis (WGCNA) was employed to identify hub genes associated with ICD. To establish diagnostic models, four machine learning techniques, including Random Forest (RF), XGBoost (XGB), Support Vector Machine (SVM), and Generalized Linear Models (GLM), were applied to filter gene sets. The receiver operating characteristic (ROC) curves were utilized to assess the performance of the models. Results: Pathway enrichment results revealed significant involvement of cytokines and chemokines among DEGs of LIRI. Immune infiltration analysis indicated higher levels of specific immune functions in Cluster 2 compared to Cluster 1.WGCNA identified significant modules linked to LIRI with strong correlations between module membership and gene significance. The RF and SVM machine learning algorithms were finally chosen to construct the models. Both demonstrated high predictive accuracy for diagnosing LIRI not only in training cohort GSE151648 but also in validation cohorts GSE23649 and GSE15480.The study highlights the pivotal roles of ICD-related genes in LIRI, providing diagnosis models with potential clinical applications for early detection and intervention strategies against LIRI.

    Keywords: liver ischemic-reperfusion injury, Immunogenic cell death, machine learning, Hub genes, Diagnosis model

    Received: 14 Dec 2024; Accepted: 28 Jan 2025.

    Copyright: © 2025 Lu, Li, Sun, Dong, Fan, Dong, Wu and Shi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Hanqi Li, Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, Shanxi, China
    Liankang Sun, Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, Shanxi, China
    Xuyuan Dong, Department of Oncology, First Affiliated Hospital of Xi'an Jiaotong University, Xi’an, 710061, Shaanxi, China
    Yangwei Fan, Department of Oncology, First Affiliated Hospital of Xi'an Jiaotong University, Xi’an, 710061, Shaanxi, China
    Danfeng Dong, Department of Oncology, First Affiliated Hospital of Xi'an Jiaotong University, Xi’an, 710061, Shaanxi, China
    Yinying Wu, Department of Oncology, First Affiliated Hospital of Xi'an Jiaotong University, Xi’an, 710061, Shaanxi, China
    Yu Shi, Department of Oncology, First Affiliated Hospital of Xi'an Jiaotong University, Xi’an, 710061, Shaanxi, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.